Literature DB >> 27799515

Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening.

Christina D Williams1,1, William M Grady1,1, Leah L Zullig1,1.   

Abstract

Colorectal cancer (CRC) remains a common cancer and significant public health burden. CRC-related mortality is declining, partly due to the early detection of CRC through robust screening. NCCN has established the NCCN Guidelines for CRC Screening to help healthcare providers make appropriate screening recommendations according to the patient's risk of developing CRC. This review describes the evolution of CRC screening guidelines for average-risk individuals, discusses the role of NCCN Guidelines for CRC Screening in cancer prevention, and comments on the current and emerging use of biomarkers for CRC screening.
Copyright © 2016 by the National Comprehensive Cancer Network.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27799515      PMCID： PMC5117951          DOI： 10.6004/jnccn.2016.0154

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


  49 in total

Review 1.  Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  David A Lieberman; Douglas K Rex; Sidney J Winawer; Francis M Giardiello; David A Johnson; Theodore R Levin
Journal:  Gastroenterology       Date:  2012-07-03       Impact factor: 22.682

2.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

3.  Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.

Authors:  Wai K Leung; Ka-Fai To; Ellen P S Man; Michael W Y Chan; Aric J Hui; Simon S M Ng; James Y W Lau; Joseph J Y Sung
Journal:  Am J Gastroenterol       Date:  2007-03-22       Impact factor: 10.864

4.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Karina W Davidson; John W Epling; Francisco A R García; Matthew W Gillman; Diane M Harper; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; Douglas K Owens; William R Phillips; Maureen G Phipps; Michael P Pignone; Albert L Siu
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

5.  Factors associated with never being screened for colorectal cancer.

Authors:  Sandte L Stanley; Jessica B King; Cheryll C Thomas; Lisa C Richardson
Journal:  J Community Health       Date:  2013-02

6.  Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly.

Authors:  Carrie N Klabunde; Yingye Zheng; Virginia P Quinn; Elisabeth F Beaber; Carolyn M Rutter; Ethan A Halm; Jessica Chubak; Chyke A Doubeni; Jennifer S Haas; Aruna Kamineni; Marilyn M Schapira; Pamela M Vacek; Michael P Garcia; Douglas A Corley
Journal:  Am J Prev Med       Date:  2016-06-22       Impact factor: 5.043

7.  Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer.

Authors:  Sabine C Glöckner; Mashaal Dhir; Joo Mi Yi; Kelly E McGarvey; Leander Van Neste; Joost Louwagie; Timothy A Chan; Wolfram Kleeberger; Adriaan P de Bruïne; Kim M Smits; Carolina A J Khalid-de Bakker; Daisy M A E Jonkers; Reinhold W Stockbrügger; Gerrit A Meijer; Frank A Oort; Christine Iacobuzio-Donahue; Katja Bierau; James G Herman; Stephen B Baylin; Manon Van Engeland; Kornel E Schuebel; Nita Ahuja
Journal:  Cancer Res       Date:  2009-05-12       Impact factor: 12.701

8.  GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.

Authors:  Debby M E I Hellebrekers; Marjolein H F M Lentjes; Sandra M van den Bosch; Veerle Melotte; Kim A D Wouters; Kathleen L J Daenen; Kim M Smits; Yoshimitsu Akiyama; Yasuhito Yuasa; Silvia Sanduleanu; Carolina A J Khalid-de Bakker; Daisy Jonkers; Matty P Weijenberg; Joost Louwagie; Wim van Criekinge; Beatriz Carvalho; Gerrit A Meijer; Stephen B Baylin; James G Herman; Adriaan P de Bruïne; Manon van Engeland
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

9.  Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.

Authors:  Graham P Lidgard; Michael J Domanico; Janelle J Bruinsma; James Light; Zubin D Gagrat; Rebecca L Oldham-Haltom; Keith D Fourrier; Hatim Allawi; Tracy C Yab; William R Taylor; Julie A Simonson; Mary Devens; Russell I Heigh; David A Ahlquist; Barry M Berger
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-29       Impact factor: 11.382

10.  Multitarget stool DNA testing for colorectal-cancer screening.

Authors:  Thomas F Imperiale; David F Ransohoff; Steven H Itzkowitz; Theodore R Levin; Philip Lavin; Graham P Lidgard; David A Ahlquist; Barry M Berger
Journal:  N Engl J Med       Date:  2014-03-19       Impact factor: 91.245
View more
  9 in total

1.  Text Message Preferences for Surveillance Colonoscopy Reminders Among Colorectal Cancer Survivors.

Authors:  Sarah D Hohl; Veena Shankaran; Ari Bell-Brown; Rachel B Issaka
Journal:  Health Educ Behav       Date:  2020-05-25

2.  Detection and analysis of common pathogenic germline mutations in Peutz-Jeghers syndrome.

Authors:  Guo-Li Gu; Zhi Zhang; Yu-Hui Zhang; Peng-Fei Yu; Zhi-Wei Dong; Hai-Rui Yang; Ying Yuan
Journal:  World J Gastroenterol       Date:  2021-10-21       Impact factor: 5.742

3.  Association of Disparities in Family History and Family Cancer History in the Electronic Health Record With Sex, Race, Hispanic or Latino Ethnicity, and Language Preference in 2 Large US Health Care Systems.

Authors:  Daniel Chavez-Yenter; Melody S Goodman; Yuyu Chen; Xiangying Chu; Richard L Bradshaw; Rachelle Lorenz Chambers; Priscilla A Chan; Brianne M Daly; Michael Flynn; Amanda Gammon; Rachel Hess; Cecelia Kessler; Wendy K Kohlmann; Devin M Mann; Rachel Monahan; Sara Peel; Kensaku Kawamoto; Guilherme Del Fiol; Meenakshi Sigireddi; Saundra S Buys; Ophira Ginsburg; Kimberly A Kaphingst
Journal:  JAMA Netw Open       Date:  2022-10-03

4.  Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma.

Authors:  Jiang-Hui Zeng; Liang Liang; Rong-Quan He; Rui-Xue Tang; Xiao-Yong Cai; Jun-Qiang Chen; Dian-Zhong Luo; Gang Chen
Journal:  Oncotarget       Date:  2017-03-07

5.  CK20 mRNA Expression in Serum as a Biomarker for Colorectal Cancer Diagnosis: A Meta-analysis.

Authors:  Baoyan Ji; Xiongfei Cheng; Xiaojun Cai; Chuiyan Kong; Qingyan Yang; Ting Fu; Yahang Wang; Ying Song
Journal:  Open Med (Wars)       Date:  2017-10-11

6.  Patient Interactions With an Automated Conversational Agent Delivering Pretest Genetics Education: Descriptive Study.

Authors:  Daniel Chavez-Yenter; Kadyn E Kimball; Wendy Kohlmann; Rachelle Lorenz Chambers; Richard L Bradshaw; Whitney F Espinel; Michael Flynn; Amanda Gammon; Eric Goldberg; Kelsi J Hagerty; Rachel Hess; Cecilia Kessler; Rachel Monahan; Danielle Temares; Katie Tobik; Devin M Mann; Kensaku Kawamoto; Guilherme Del Fiol; Saundra S Buys; Ophira Ginsburg; Kimberly A Kaphingst
Journal:  J Med Internet Res       Date:  2021-11-18       Impact factor: 5.428

7.  A Retrospective Study from a Single Center to Identify Hematological Factors that Distinguish Between Patients with Colorectal Carcinoma and Colorectal Adenoma.

Authors:  Jun Huang; Pingping Xu; Youxiang Chen
Journal:  Med Sci Monit       Date:  2022-08-10

8.  Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer.

Authors:  Zhiyu Wang; Aimin Zang; Yaning Wei; Lin An; Dan Hong; Yan Shi; Jingnan Zhang; Shenyong Su; Guotao Fang
Journal:  Drug Des Devel Ther       Date:  2020-03-12       Impact factor: 4.162

9.  Mutation analysis of related genes in hamartoma polyp tissue of Peutz-Jeghers syndrome.

Authors:  Zhi Zhang; Fu-Xiao Duan; Guo-Li Gu; Peng-Fei Yu
Journal:  World J Gastroenterol       Date:  2020-04-28       Impact factor: 5.742
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.